)
Anna Schuh
Director of Molecular Diagnostics,
University of Oxford
Professor Anna Schuh has led over 50 early- and late-phase clinical trials in chronic lymphocytic leukaemia as a principal or chief investigator. Her main laboratory research interest is the development, evaluation and implementation of new technologies for precision diagnostics, most recently whole genome sequencing and liquid biopsy testing. Together with colleagues from primary care, she leads a programme in the NHS evaluating multi-cancer early detection tools to triage patients with non-specific symptoms of cancer, and using liquid biopsies for faster diagnosis of children with Burkitt lymphoma in sub-Saharan Africa.
She also spearheaded the creation of an online, part-time Oxford MSc Programme in Precision Cancer Medicine.
Sessions
-
Multimodal Liquid Biopsy for Early Cancer Detection: From Methylation to Single-Molecule Sequencing28-Jan-2027Cancer Diagnostics Stage